Viewing Study NCT00564512

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-26 @ 10:17 PM
Ignite Modification Date: 2025-12-30 @ 6:25 AM
Study NCT ID: NCT00564512
Status: COMPLETED
Last Update Posted: 2013-07-25
First Post: 2007-11-27
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Fludarabine, Cyclophosphamide, and Rituximab or Alemtuzumab in Treating CLL2007 CLL 2007 FMP
Sponsor: French Innovative Leukemia Organisation
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Leukemia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None B-cell chronic lymphocytic leukemia View
None stage I chronic lymphocytic leukemia View
None stage II chronic lymphocytic leukemia View
None stage III chronic lymphocytic leukemia View
None stage IV chronic lymphocytic leukemia View